StonvexLoading…
StonvexStonvexStonvexCore line items from VHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.08B | $2.10B | $1.92B | $2.22B |
Operating Income | $63.30M | $210.70M | $34.20M | $239.40M |
Net Income | $-57.60M | $108.00M | $-9.90M | $87.20M |
EPS (Diluted) | $-2.02 | $3.79 | $-0.35 | $3.06 |
Total Assets | $2.63B | $2.80B | $2.74B | $2.84B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $214.00M | $348.30M | $407.00M | $478.50M |
Free Cash Flow OCF − CapEx | $-82.10M | $13.10M | $-44.60M | $-32.70M |
Shares Outstanding | 29.60M | 29.60M | 29.60M | 29.60M |